Dedicated to ensuring the success of the bioscience industry in the state of Connecticut.

The BioCT Leadership and Board of Directors brings industry expertise, advice, and support to the Connecticut bioscience community. This team looks forward to serving as mentors and advisors to our members.

BioCT Leadership

Dawn Hocevar
President & CEO, BioCT
BioCT

Stanley Choy, M.B.A.
Chair & Treasurer, BioCT
Bioscience Entrepreneur

Paul Hughes, J.D.
Secretary, BioCT
Partner, Wiggin and Dana, LLP

BioCT Board of Directors

Mostafa Analoui, Ph.D.
Bioscience Leader

Abhijit (Jit) Banerjee, PhD, MBA
Associate Vice President, Innovation & Entrepreneurship,
University of Connecticut

Robert Bettigole, MPPM
Managing Partner,
Elm Street Ventures

Stanley Choy, M.B.A.
Bioscience Entrepreneur

Josh Geballe, M.B.A.
Senior Associate Provost for Entrepreneurship and Innovation, Yale University;
Managing Director, Yale Ventures

Cynthia D. Green, Ph.D., M.B.A.
Managing Director,
Connecticut Innovations (CI)

Dawn Hocevar
President & CEO,
BioCT

John G. Houston, Ph.D.
President & CEO,
Arvinas

Paul Hughes, J.D.
Partner,
Wiggin and Dana, LLP

Raja Mangipudy, Ph.D.
Senior Vice President, Global Head of Drug Safety Research
and Development, Groton Site Director, Pfizer

David I. Scheer, M.S.
President,
Scheer and Company

Jackie Schumacher
Head of Regulatory and Quality,
Rallybio

Eleanore Seibert, Ph.D.
Vice-President, Drug Metabolism & Pharmacokinetics,
Boehringer Ingelheim Pharmaceuticals, Inc.

Erika Smith, M.B.A.
CEO,
ReNetX Bio, Inc

J. Dormer Stephen, J.D.
Partner,
Shipman & Goodwin, LLP

Kaile Zagger
Bioscience Executive

Directors Emeriti

Kevin Rakin
Co-Founder,
HighCape Partners

David W. Keiser
Director,
Tetherex Pharmaceuticals

Peter Farina, Ph.D. 
Executive in Residence,
Canaan Partners

Frank J. Marco, J.D.
Special Counsel,
Wiggin and Dana, LLP

Harry H. Penner, Jr., LL.M.
Co-Founder &Chairman,
Affinimark

Past President & CEO

Susan Froshauer, Ph.D.
Past President & CEO,
BioCT